- Gentamicin 225mg implant
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Gentamicin 225mg implant | Start Date 29-11-2004 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- device
- Unit Dose UOM
- device
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intralesional
- Form
- Prolonged-release intralesional implant
- Ontology Form/Route
- implant.intralesional
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- J01GB03
Code | Start Date | End Date |
---|---|---|
8750011000001100 | 29-11-2004 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Gentamicin sulfate | Based on Ingredient Substance | 225 mg |
Name
Gentamicin sulfate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
225
Strength and UOM (Dmr)
Parent Products
-
VTMGentamicin
-
VMP(Current) Gentamicin 225mg implant
-
AMP
No AMPs
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
1 device |